Golimumab, SCH 900259, MK-8259, CNTO-148: A Comparative Review This analysis reviews four distinct therapies : golimumab, SCH 900259, MK-8259, and CNTO-148. Golimumab, a well-established monoclonal targeting https://www.targetmol.com/compound/golimumab